Tuberculosis (TB) represents an infection with Mycobacterium Tuberculosis. Known since ancient Egypt, it became the scourge of 19th century Europe and North America. There has been exponential decline in the prevalence of TB in the 20th century and the advent of anti TB drugs has further diminished the impact of the disease. However, the recent emergence of drug-resistant strains, particularly among patients with AIDS, has rekindled interest in TB.
The Biorex Diagnostics Tuberculosis IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a membrane-based screening test for the rapid detection of IgM anti-Mycobacterium Tuberculosis and IgG anti-Mycobacterium Tuberculosis in human whole blood, serum or plasma. This innovative rapid screening test is based on lateral flow immunochromatography and is among the easiest point of care (POC) assay diagnostics. The results obtained should not be the sole determinant for clinical decision. All positive specimens must be confirmed with other confirmatory methods.